Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progress for patients with melanoma brain metastases.
Sperduto PW, Salama AKS, Anders C. Sperduto PW, et al. Among authors: salama aks. Neuro Oncol. 2023 Jul 6;25(7):1321-1322. doi: 10.1093/neuonc/noad050. Neuro Oncol. 2023. PMID: 36883201 Free PMC article. No abstract available.
Current multidisciplinary management of brain metastases.
Moravan MJ, Fecci PE, Anders CK, Clarke JM, Salama AKS, Adamson JD, Floyd SR, Torok JA, Salama JK, Sampson JH, Sperduto PW, Kirkpatrick JP. Moravan MJ, et al. Among authors: salama jk, salama aks. Cancer. 2020 Apr 1;126(7):1390-1406. doi: 10.1002/cncr.32714. Epub 2020 Jan 23. Cancer. 2020. PMID: 31971613 Free article. Review.
A Need for More Molecular Profiling in Brain Metastases.
Shen E, Van Swearingen AED, Price MJ, Bulsara K, Verhaak RGW, Baëta C, Painter BD, Reitman ZJ, Salama AKS, Clarke JM, Anders CK, Fecci PE, Goodwin CR, Walsh KM. Shen E, et al. Among authors: salama aks. Front Oncol. 2022 Jan 25;11:785064. doi: 10.3389/fonc.2021.785064. eCollection 2021. Front Oncol. 2022. PMID: 35145903 Free PMC article. Review.
Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain Metastases.
Vaios EJ, Shenker RF, Hendrickson PG, Wan Z, Niedzwiecki D, Winter SF, Shih HA, Dietrich J, Wang C, Salama AKS, Clarke JM, Allen K, Sperduto P, Mullikin T, Kirkpatrick JP, Floyd SR, Reitman ZJ. Vaios EJ, et al. Among authors: salama aks. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1507-1518. doi: 10.1016/j.ijrobp.2023.12.002. Epub 2023 Dec 12. Int J Radiat Oncol Biol Phys. 2024. PMID: 38097090 Free PMC article.
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Ribas A, Puzanov I, Dummer R, Schadendorf D, Hamid O, Robert C, Hodi FS, Schachter J, Pavlick AC, Lewis KD, Cranmer LD, Blank CU, O'Day SJ, Ascierto PA, Salama AK, Margolin KA, Loquai C, Eigentler TK, Gangadhar TC, Carlino MS, Agarwala SS, Moschos SJ, Sosman JA, Goldinger SM, Shapira-Frommer R, Gonzalez R, Kirkwood JM, Wolchok JD, Eggermont A, Li XN, Zhou W, Zernhelt AM, Lis J, Ebbinghaus S, Kang SP, Daud A. Ribas A, et al. Lancet Oncol. 2015 Aug;16(8):908-18. doi: 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115796 Free PMC article. Clinical Trial.
83 results